![Mads Dall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mads Dall
Direktor/Vorstandsmitglied bei
ADOCIA
Profil
Mads Dall is currently an Independent Director at Adocia SA since 2023.
Former roles include President & Chief Executive Officer at iSTAR Medical SA, Director at Mendor Oy, Director at Eyenuk, Inc., Director at Beta Bionics, Inc. from 2022 to 2023, Vice President at Novo Nordisk A, Executive VP-Strategy & Business Development at CeQur SA, and Chief Commercial Officer at Beta Bionics, Inc. Education includes graduate degrees from Copenhagen Business School and the University of Copenhagen.
Aktive Positionen von Mads Dall
| Unternehmen | Position | Beginn |
|---|---|---|
| ADOCIA | Direktor/Vorstandsmitglied | 11.05.2023 |
Dall & Co. ApS | Vorstandsvorsitzender | - |
Esther og Martin Dalls Fond
 Esther og Martin Dalls Fond Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Vorsitzender | - |
Ehemalige bekannte Positionen von Mads Dall
| Unternehmen | Position | Ende |
|---|---|---|
| BETA BIONICS, INC. | Direktor/Vorstandsmitglied | 01.12.2023 |
Eyenuk, Inc.
 Eyenuk, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diabetic retinopathy diagnostic devices | Direktor/Vorstandsmitglied | - |
iSTAR Medical SA
 iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Vorstandsvorsitzender | - |
| BETA BIONICS, INC. | Corporate Officer/Principal | - |
Mendor Oy
 Mendor Oy BiotechnologyHealth Technology Designs, develops and markets diabetes management products | Direktor/Vorstandsmitglied | - |
Ausbildung von Mads Dall
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
CeQur SA
 CeQur SA Medical SpecialtiesHealth Technology Develops medical devices for diabetes patients | Health Technology |
Mendor Oy
Mendor Oy BiotechnologyHealth Technology Designs, develops and markets diabetes management products | Health Technology |
iSTAR Medical SA
iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Health Technology |
Eyenuk, Inc.
Eyenuk, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diabetic retinopathy diagnostic devices | Health Technology |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Esther og Martin Dalls Fond
Esther og Martin Dalls Fond Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Dall & Co. ApS |
Wählen Sie MarketScreener 
